Next Quarterly Earnings
Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Arbutus Biopharma
Arbutus Biopharma is a US-based biopharmaceutical company specializing in the development of innovative therapies for chronic hepatitis B (HBV). By utilizing advanced RNA interference technologies and antiviral agents, the company aims to achieve a functional cure for patients living with the disease.
Frequently asked questions
When will Arbutus Biopharma report its next quarterly earnings?
Arbutus Biopharma is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Arbutus Biopharma last report quarterly earnings?
Arbutus Biopharma last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -0.03 USD.
How does Arbutus Biopharma stock react to earnings?
Across its last 3 earnings reports, Arbutus Biopharma stock moved by ±2% on average the following day. The largest reaction was +4.3% on 03/23/2026; 1 of 3 reactions were positive.
How often has Arbutus Biopharma beaten expectations?
Arbutus Biopharma has beaten analyst EPS estimates in 4 of its last 6 evaluated quarters (beat rate: 66.7%).
How do I add the Arbutus Biopharma earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2%
Avg. next-day move
+4.3%
Largest move (03/23/2026)
33.3%
Share of positive reactions
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/6
Quarters above estimates
66.7%
Beat rate
+503.8%
Avg. EPS surprise
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Arbutus Biopharma
Country
🇺🇸
More Financial Information